BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 15942442)

  • 1. Better survival in female patients with hepatocellular carcinoma: oral contraceptive pills related?
    Lam CM; Yong JL; Chan AO; Ng KK; Poon RT; Liu CL; Lo CM; Fan ST
    J Clin Gastroenterol; 2005 Jul; 39(6):533-9. PubMed ID: 15942442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new prognostic score can predict survival after hepatocellular carcinoma treatment in a cohort of 1302 Egyptian hepatocellular carcinoma patients.
    Abdelaziz AO; Shousha HI; Abdelmaksoud AH; Saad Y; Elbaz TM; Soliman ZA; Salah A; Lithy R; Ahmed M; Nabil MM
    Eur J Gastroenterol Hepatol; 2018 May; 30(5):514-519. PubMed ID: 29465472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival and prognostic factors in patients with hepatocellular carcinoma treated by percutaneous ethanol injection: a 10-year experience.
    Mazzanti R; Arena U; Pantaleo P; Antonuzzo L; Cipriani G; Neri B; Giordano C; Lanini F; Marchetti S; Gentilini P
    Can J Gastroenterol; 2004 Oct; 18(10):611-8. PubMed ID: 15497001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
    World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of spontaneous rupture of hepatocellular carcinoma: single-center experience.
    Liu CL; Fan ST; Lo CM; Tso WK; Poon RT; Lam CM; Wong J
    J Clin Oncol; 2001 Sep; 19(17):3725-32. PubMed ID: 11533094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poor prognosis for hepatocellular carcinoma with transarterial chemoembolization pre-transplantation: retrospective analysis.
    Li HL; Ji WB; Zhao R; Duan WD; Chen YW; Wang XQ; Yu Q; Luo Y; Dong JH
    World J Gastroenterol; 2015 Mar; 21(12):3599-606. PubMed ID: 25834326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural history of untreated nonsurgical hepatocellular carcinoma.
    Yeung YP; Lo CM; Liu CL; Wong BC; Fan ST; Wong J
    Am J Gastroenterol; 2005 Sep; 100(9):1995-2004. PubMed ID: 16128944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppressive effects of entecavir on hepatitis B virus and hepatocellular carcinoma.
    Jin YJ; Shim JH; Lee HC; Yoo DJ; Kim KM; Lim YS; Suh DJ
    J Gastroenterol Hepatol; 2011 Sep; 26(9):1380-8. PubMed ID: 21884247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors for survival after transarterial chemoembolization combined with microwave ablation for hepatocellular carcinoma.
    Ni JY; Sun HL; Chen YT; Luo JH; Chen D; Jiang XY; Xu LF
    World J Gastroenterol; 2014 Dec; 20(46):17483-90. PubMed ID: 25516662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocellular carcinoma during pregnancy and its comparison with other pregnancy-associated malignancies.
    Lau WY; Leung WT; Ho S; Lam SK; Li CY; Johnson PJ; Williams R; Li AK
    Cancer; 1995 Jun; 75(11):2669-76. PubMed ID: 7743468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of curative treatment for hepatocellular cancer in nonalcoholic steatohepatitis versus hepatitis C and alcoholic liver disease.
    Reddy SK; Steel JL; Chen HW; DeMateo DJ; Cardinal J; Behari J; Humar A; Marsh JW; Geller DA; Tsung A
    Hepatology; 2012 Jun; 55(6):1809-19. PubMed ID: 22183968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphoepithelioma-like hepatocellular carcinoma: an uncommon variant of hepatocellular carcinoma with favorable outcome.
    Chan AW; Tong JH; Pan Y; Chan SL; Wong GL; Wong VW; Lai PB; To KF
    Am J Surg Pathol; 2015 Mar; 39(3):304-12. PubMed ID: 25675010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival benefit of cirrhotic patients with hepatocellular carcinoma treated by percutaneous ethanol injection as a salvage therapy.
    Huo TI; Huang YH; Wu JC; Lee PC; Chang FY; Lee SD
    Scand J Gastroenterol; 2002 Mar; 37(3):350-5. PubMed ID: 11916199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chemoembolization of hepatocellular carcinomas: which factors determine therapeutic response and survival?].
    Huppert PE; Lauchart W; Duda SH; Torkler C; Kloska SP; Weinlich M; Benda N; Pereira P; Claussen CD
    Rofo; 2004 Mar; 176(3):375-85. PubMed ID: 15026951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes mellitus may affect the long-term survival of hepatitis B virus-related hepatocellular carcinoma patients after liver transplantation.
    Zhang Q; Deng YL; Liu C; Huang LH; Shang L; Chen XG; Wang LT; Du JZ; Wang Y; Wang PX; Zhang H; Shen ZY
    World J Gastroenterol; 2016 Nov; 22(43):9571-9585. PubMed ID: 27920478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients with non-viral liver disease have a greater tumor burden and less curative treatment options when diagnosed with hepatocellular carcinoma.
    Mohsen W; Rodov M; Prakoso E; Charlton B; Bowen DG; Koorey DJ; Shackel NA; McCaughan GW; Strasser SI
    World J Gastroenterol; 2017 Apr; 23(15):2763-2770. PubMed ID: 28487614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hepatocellular carcinoma: the significance of cirrhosis for treatment and prognosis--retrospective study].
    Witjes CD; de Man RA; Eskens FA; Dwarkasing RS; Zondervan PE; Verhoef C; Ijzermans JN
    Ned Tijdschr Geneeskd; 2010; 154():A1747. PubMed ID: 20719013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment choice for early-stage hepatocellular carcinoma in real-world practice: impact of treatment stage migration to transarterial chemoembolization and treatment response on survival.
    Roberts SK; Gazzola A; Lubel J; Gow P; Bell S; Nicoll A; Dev A; Fink MA; Sood S; Knight V; Hong T; Paul E; Mishra G; Majeed A; Kemp W;
    Scand J Gastroenterol; 2018; 53(10-11):1368-1375. PubMed ID: 30394145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of disease stage and aetiology on survival in hepatocellular carcinoma: implications for surveillance.
    Johnson P; Berhane S; Kagebayashi C; Satomura S; Teng M; Fox R; Yeo W; Mo F; Lai P; Chan SL; Tada T; Toyoda H; Kumada T
    Br J Cancer; 2017 Feb; 116(4):441-447. PubMed ID: 28081537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoembolization of recurrent hepatoma after curative resection: prognostic factors.
    Zu QQ; Liu S; Zhou CG; Yang ZQ; Xia JG; Zhao LB; Shi HB
    AJR Am J Roentgenol; 2015 Jun; 204(6):1322-8. PubMed ID: 26001244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.